Tsudome R, Suematsu Y, Tashiro K, Ideishi A, Miyazaki M, Yano Y, et al. Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction. Cardiol Res [Internet]. 2025 Dec. 20 [cited 2025 Dec. 21];16(6):489-98. Available from: https://cr.elmerpub.com/index.php/cr/article/view/2109